Contrave Tablet (Extended Release) (2018-08-06)
- Starting date:
- August 6, 2018
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type II
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-67546
Recalled Products
Contrave Tablet (Extended Release)
Reason
The bottles of affected lots could be perforated.
Depth of distribution
Retailers
Affected products
Contrave Tablet (Extended Release)
DIN, NPN, DIN-HIM
DIN 02472945
Dosage form
Tablet (Extended Release)
Strength
Bupropion hydrochloride 90mg
Naltrexone hydrochloride 8mg
Lot or serial number
ZNPZ, ZNSC
Companies
- Recalling Firm
-
Valeant Canada LP
2150 St-Elzear Boulevard West,
Laval
H7L 4A8
Quebec
CANADA
- Marketing Authorization Holder
-
Valeant Canada LP
2150 St-Elzear Boulevard West,
Laval
H7L 4A8
Quebec
CANADA